Camrelizumab/rivoceranibVarious toxicities: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1939卷 / 1期

关键词：

D O I：

10.1007/s40278-023-31534-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：126 / 126

相关论文

共 50 条

[1] Camrelizumab/rivoceranibVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1811 (1) : 79 - 79
[2] Camrelizumab/rivoceranibVarious toxicities: 6 case reports
Reactions Weekly, 2022, 1925 (1) : 145 - 145
[3] Camrelizumab/rivoceranibVarious toxicities: case report
Reactions Weekly, 2019, 1776 (1) : 106 - 106
[4] Camrelizumab/irinotecan/rivoceranibVarious toxicities and lack of efficacy: 6 case reports
Reactions Weekly, 2023, 1986 (1) : 119 - 119
[5] RivoceranibVarious toxicities: 4 case reports
Reactions Weekly, 2021, 1859 (1) : 332 - 332
[6] RivoceranibVarious toxicities: 3 case reports
Reactions Weekly, 2018, 1703 (1) : 239 - 239
[7] RivoceranibVarious toxicities: 5 case reports
Reactions Weekly, 2020, 1825 (1) : 191 - 191
[8] RivoceranibVarious toxicities: 8 case reports
Reactions Weekly, 2019, 1747 (1) : 256 - 256
[9] RivoceranibVarious toxicities: 2 case reports
Reactions Weekly, 2024, 2022 (1) : 250 - 250
[10] RivoceranibVarious toxicities: 2 case reports
Reactions Weekly, 2018, 1694 (1) : 386 - 386

← 1 2 3 4 5 →